Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: Facing the challenge of a proper study design

2000-05-01

Additional Metadata
Keywords	Clinical studies, Cytostatic anticancer agents, Design, Phase I, Phase II, Phase III
Persistent URL	doi.org/10.1016/S1040-8428(00)00055-X, hdl.handle.net/1765/67716
Journal	Critical Reviews in Oncology / Hematology
Organisation	Department of Medical Oncology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Eskens, F.A.L.M, & Verweij, J. (2000). Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: Facing the challenge of a proper study design. Critical Reviews in Oncology / Hematology, 34(2), 83–88. doi:10.1016/S1040-8428(00)00055-X

Publication